Passive micromixer with baffles distributed on both sides of microchannels based on the Koch fractal principle

Since the beginning of the 21st Century, the development of microfluidic chip technology has been very rapid and has attracted the attention of more and more scholars. As an important part of the microfluidic chip, the performance of the micromixer is critical. The fractal structure in the microchannels helps to improve the mixing performance of the micromixer and improve the mixing efficiency of the micromixer. The research results of other scholars are of great significance to the research of the present paper, which mainly studies the effect of changing the baffle state on the mixing efficiency of the micromixer based on the Koch fractal principle. Through simulation analysis, it was found that the mixing efficiency of the baffles distributed on both sides of the microchannel was higher than the mixing efficiency of the baffles distributed on the microchannel side. When the distance between adjacent baffles was divided into 0.15, 0.25 and 0.35 mm, simulated data suggested that the baffle distance of 0.15 mm was best. Increasing the number of baffles from six to eight groups increased the mixing path of the fluid in the microchannel and improved mixing efficiency. A comparison of mixing efficiencies of the 0°, 15° and 30° baffle angles revealed that very significant improvement in mixing efficiency was obtained at 30°. © 2019 Society of Chemical Industry     

高性能碳基储能材料的设计、合成与应用

电化学储能器件的性能很大程度上决定于其电极材料。碳材料具有来源广泛、化学稳定性好、易于调控、环境友好等优点，被广泛应用于各类能量存储系统，但仍存在能量密度低、倍率性能差等问题。本文从碳材料孔结构调控、杂原子掺杂、与金属氧化物复合三个角度，综述了构建高性能碳基储能材料的设计合成策略，介绍了其在锂/钠离子二次电池、超级电容器等领域的研究进展，对几种方法策略的优缺点进行了总结，并对未来的研究方向进行了展望。本文对高性能碳基储能电极材料的设计开发具有积极意义。     

模内装饰薄膜滞热对成型工艺的影响分析

以模内装饰技术(IMD)测试平板为研究对象，利用仿真和实验方法分析薄膜滞热的影响因素及薄膜滞热对成型工艺的影响规律。结果表明，薄膜滞热使动模侧模具温度场变化滞后于定模侧温度场，且在实验条件下达到8.6 ℃的最大温度差；薄膜滞热随着模具温度的增加而降低，随熔体温度和薄膜厚度增加而升高；薄膜影响熔体的充模与冷却，造成产品冷却不均的现象；薄膜滞热导致产品翘曲变形增加。     

溶液浓差能驱动的逆电渗析反应器制氢实验研究

低品位热能制氢技术首先是将热能转换为溶液浓差能，然后通过逆电渗析（RED）反应器将溶液浓差能转换成氢能。为了验证RED反应器能将溶液浓差能转换为氢能，探索关键运行参数变化对能量转换过程的影响。设计了一个由40个膜对所构成的RED反应器，以NaCl水溶液为工作溶液，NaOH水溶液为电极液的制氢系统。通过改变浓/稀溶液入口浓度，溶液过膜流速以及输出电流来考察对RED反应器产氢率、制氢效率和能量转换效率的影响。实验结果发现，浓/稀溶液入口浓度，过膜流速变化均会影响RED反应器的输出电流。在外电路短接条件下，输出电流越大，反应器产氢率和制氢效率越高，但能量转换效率越低。     

三种硫化氢吸收剂吸收效率对比及碘酸钾体系吸收条件优化研究

硫化氢具有腐蚀性与毒性，采用吸收剂吸收硫化氢气体是重要的脱硫处理方式。不同的吸收剂在吸收效率上存在较大差别。首先对比了三氯化铁体系、碘酸钾体系和碱性铁氰化钾体系三种不同硫化氢吸收剂的吸收效率。在此基础上重点优化了碘酸钾体系吸收条件参数，讨论了包含浓度、温度、pH、气体流量及时间等因素对硫化氢吸收效率的影响。并建立了四因素三水平正交试验研究较优吸收条件，得到正交试验优化吸收条件为：温度55℃，pH 6.01，硫化氢流量0.3 L·min^-1，吸收时间1 min，该条件下8%（质量）碘酸钾体系的三级吸收效率为51.56%。研究结果对硫化氢吸收处理提供了理论参考，也为间接电解法循环处理研究提供了支持。     

泳池式轻水反应堆内电磁线圈可控温辐照装置设计

本文设计了在泳池式轻水反应堆（简称泳池堆）内在线测量电磁线圈电性能的可控温辐照装置。采用MCNP程序进行中子物理计算，对泳池堆、线圈骨架的结构尺寸与物质组分进行了精细全尺寸模拟，得出辐照装置的发热功率和中子注量率。通过初步估算，使用ANSYS CFX进行了数值模拟，得出辐照装置内线圈在堆运行时的温度，并提出温度控制的方法。辐照装置采用铝材加工制造，并进行了垂直度测试、气压测试、检漏测试。增加了绝缘设计，将辐照装置与泳池堆之间进行绝缘。在线圈处预埋铠装热电偶，对线圈温度进行实时监测。在泳池堆内对电磁线圈进行辐照试验，结果表明，本文设计的辐照装置能满足电磁线圈在泳池堆孔道内进行辐照试验的要求，并可对电磁线圈进行实时温度控制。     

急性炎性疾病患者乳酸林格氏液液体动力学

目的:探索炎性疾病患者的乳酸林格氏液（Ringer's lactate,RL）液体动力学特征以及炎性生物标记物是否可以作为协变量影响RL分布和排泄。方法:本研究为前瞻性队列研究。选择40例美国麻醉医师分级（ASA）I-II级，腹腔镜下择期胆囊切除术（胆囊炎组，n=20）或者腹腔镜下急诊阑尾切除术（阑尾炎组，n=20）。所有患者麻醉诱导前开始输注RL，按15 mL/kg，35 min内输毕。采用酶联免疫（enzyme-linked immunosorbent assay,ELISA）方法测定血浆炎症（TNF-α,IL-10和CRP）或者内皮损伤生物标记物（syndecan-1,SDC-1）；利用血红蛋白（Hb）稀释-时间曲线和尿量，使用Phoenix软件，采用非线性混合效应模型分析计算RL液体动力学参数和协变量的影响。结果:与胆囊炎组相比，阑尾炎组RL从组织间隙到血浆的转运速率常数（k21）显著降低（14×10-3min-1 versus 35×10-3min-1;P=0.012）。阑尾炎组C反应蛋白（CRP）升高［中位数38.1(1.8-143.6) μg/mL versus 1.3(0.1-159.0) μg/mL;P<0.001］；与清醒状态相比，麻醉期间（输液开始后30～45 min），液体从中央室中到外周室的转运速率常数（k12）显著增加（57×10-3min-1 versus 32×10-3min-1；P<0.01）。清除速率常数（k10）降低90%（0.6×10-3min-1 versus 5.3×10-3min-1;P<0.001）。无论在清醒状态还是麻醉状态下低血压均能降低液体清除；炎症或者内膜损伤的生物标记物不能作为显著影响RL液体动力学参数的协变量。结论:阑尾炎或者胆囊炎患者术前输入液体后“炎症反应的生物标记物”不是RL的液体动力学的协变量，但是两组患者中，全身麻醉期间输入液体的清除率下降。     

Long-term sustained-released in situ gels of a water-insoluble drug amphotericin B for mycotic arthritis intra-articular administration: preparation,in vitro and in vivo evaluation

Amphotericin B (AMB) was often used in intra-articular injection administration for fungal arthritis, because it could often bring a satisfactory therapeutic efficacy and a minimum systemic toxic side effect. However, because of the multiple operations and the frequent injections, the compliance of the patients was bad. Therefore, to develop a long-term sustained-released preparation of AMB for mycotic arthritis intra-articular administration is of great significance. The purpose of present study was to develop a long-term sustained-released in situ gel of a water-insoluble drug AMB for mycotic arthritis intra-articular administration. Based on the evaluations of the in vitro properties of the formulations, the formulation containing 10% (w/w) ethanol, 15% (w/w) PG, 0.75% (w/w) HA, 5% (w/w) purified soybean oil, 0.03% (w/w) α-tocopherol, 15% (w/w) water and 55% (w/w) glyceryl monooleate was selected as a suitable intra-articular injectable in situ gel drug delivery system for water-insoluble drug AMB. Furthermore, the results of the in vivo study on rabbits showed that the selected formulation was a safe and effective long-term sustained-released intra-articular injectable AMB preparation. Therefore, the presented in situ AMB gel could reduce the frequency of the administration in the AMB treatment of fungal arthritis, and then would get a good patient compliance.     

Nanomaterials for radiotherapeutics-based multimodal synergistic cancer therapy

Over the past decade, numerous studies have attempted to enhance the effectiveness of radiotherapy (external beam radiotherapy and internal radioisotope therapy) for cancer treatment. However, the low radiation absorption coefficient and radiation resistance of tumors remain major critical challenges for radiotherapy in the clinic. With the development of nanomedicine, nanomaterials in combination with radiotherapy offer the possibility to improve the efficiency of radiotherapy in tumors. Nanomaterials act not only as radiosensitizers to enhance radiation energy, but also as nanocarriers to deliver therapeutic units in combating radiation resistance. In this review, we discuss opportunities for a synergistic cancer therapy by combining radiotherapy based on nanomaterials designed for chemotherapy, photodynamic therapy, photothermal therapy, gas therapy, genetic therapy, and immunotherapy. We highlight how nanomaterials can be utilized to amplify antitumor radiation responses and describe cooperative enhancement interactions among these synergistic therapies. Moreover, the potential challenges and future prospects of radio-based nanomedicine to maximize their synergistic efficiency for cancer treatment are identified.

     

A Preamble Re-utilizing Access Scheme for Machine-Type Communications with Optimal Access Class Barring

Wireless Personal Communications - The existing long term evolution networks originally designed for human-to-human communications are hard to tackle numerous and bursty random access requests from...